Swipe om te navigeren naar een ander artikel
We draw attention to a number of important considerations in the arguments about screening and outcome of intervention in children with autism and other developmental disorders. Autism screening in itself never provides a final clinical diagnosis, but may well identify developmental deviations indicative of autism—or of other developmental disorders—that should lead to referral for further clinical assessment. Decisions regarding population or clinic screening cannot be allowed to be based on the fact that prospective longitudinal RCT designs over decades could never be performed in complex developmental disorders. We propose an alternative approach. Early screening for autism and other developmental disorders is likely to be of high societal importance and should be promoted and rigorously evaluated.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Allaby, M., & Sharma, M. (2011). Screening for Autism Spectrum Disorders in Children below the age of 5 years. A draft report for the UK National Screening Committee. Solutions for Public Health.
Reichow, B., Barton, E. E., Boyd, B. A., & Hume, K. (2012). Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Systematic Review, 10, CD009260.
Weijer, C., Grimshaw, J. M., Eccles, M. P., McRae, A. D., White, A., Brehaut, J. C., et al. (2012). Ottawa ethics of cluster randomized trials consensus group. The Ottawa statement on the ethical design and conduct of cluster randomized trials. PLoS Medicine, 9(11), e1001346. PubMedCentralPubMedCrossRef
- Screening, Intervention and Outcome in Autism and Other Developmental Disorders: The Role of Randomized Controlled Trials
- Springer US